Flores, Rosalie C.
HRN: 13-38-70 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2022
CO-AMOXICLAV 625MG (TAB)
05/16/2022
05/23/2022
PO
625
BID
UTI
Waiting Final Action